Analysis of Triclosan-Selected Salmonella enterica Mutants of Eight Serovars Revealed Increased Aminoglycoside Susceptibility and Reduced Growth Rates

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Rensch, Ulrike ^a   Klein, Guenter ^a   Kehrenberg, Corinna ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CHLORHEXIDINE; GENTAMICIN; KANAMYCIN; TRICLOSAN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN;

ACRA GENE; ACRF GENE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM TRANSFORMATION; CELL SUSPENSION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG TOLERANCE; FABL GENE; GENE EXPRESSION; GENE MUTATION; GENE PRODUCT; GROWTH RATE; MARA GENE; MINIMUM INHIBITORY CONCENTRATION; MUTANT PREVENTION CONCENTRATION; NONHUMAN; OPTICAL DENSITY; RAMA GENE; REGULATOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALMONELLA ENTERICA; SALMONELLA ENTERITIDIS; SALMONELLA HADAR; SALMONELLA INFANTIS; SALMONELLA LIVINGSTONE; SALMONELLA PARATYPHI B; SALMONELLA SAINTPAUL; SALMONELLA TYPHIMURIUM; SALMONELLA VIRCHOW; SEROTYPE; SOXS GENE; TOLC GENE; UPREGULATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE; MUTATION; PROCEDURES;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MUTATION; SALMONELLA ENTERICA; SEROGROUP; TRICLOSAN;

EID: 84885707796     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078310     Document Type: Article

References (43)

1. Condell O, Sheridan Á, Power KA, Bonilla-Santiago R, Sergeant K, et al. (2012) Comparative proteomic analysis of Salmonella tolerance to the biocide active agent triclosan. J Proteomics 75: 4505-4519. doi:10.1016/j.jprot.2012.04.044. PubMed: 22579747.
2. Whitehead RN, Overton TW, Kemp CL, Webber MA, (2011) Exposure of Salmonella enterica serovar Typhimurium to high level biocide challenge can select multidrug resistant mutants in a single step. PLOS ONE 6: e22833. doi:10.1371/journal.pone.0022833. PubMed: 21829527.
3. Condell O, Iversen C, Cooney S, Power KA, Walsh C, et al. (2012) Efficacy of biocides used in the modern food industry to control Salmonella enterica, and links between biocide tolerance and resistance to clinically relevant antimicrobial compounds. Appl Environ Microbiol 78: 3087-3097. doi:10.1128/AEM.07534-11. PubMed: 22367085.
4. Karatzas KA, Webber MA, Jorgensen F, Woodward MJ, Piddock LJ, et al. (2007) Prolonged treatment of Salmonella enterica serovar Typhimurium with commercial disinfectants selects for multiple antibiotic resistance, increased efflux and reduced invasiveness. J Antimicrob Chemother 60: 947-955. doi:10.1093/jac/dkm314. PubMed: 17855722.
5. Cerf O, Carpentier B, Sanders P, (2010) Tests for determining in-use concentrations of antibiotics and disinfectants are based on entirely different concepts: "resistance" has different meanings. Int J Food Microbiol 136: 247-254. doi:10.1016/j.ijfoodmicro.2009.10.002. PubMed: 19853944.
6. Middleton JH, Salierno JD, (2013) Antibiotic resistance in triclosan tolerant fecal coliforms isolated from surface waters near wastewater treatment plant outflows (Morris County, NJ, USA). Ecotoxicol Environ Saf 88: 79-88. doi:10.1016/j.ecoenv.2012.10.025. PubMed: 23195806.
7. Hernández A, Ruiz FM, Romero A, Martínez JL, (2011) The binding of triclosan to SmeT, the repressor of the multidrug efflux pump SmeDEF, induces antibiotic resistance in Stenotrophomonas maltophilia. PLOS Pathog 7: e1002103. PubMed: 21738470.
8. Dann AB, Hontela A, (2011) Triclosan: environmental exposure, toxicity and mechanisms of action. J Appl Toxicol 31: 285-311. doi:10.1002/jat.1660. PubMed: 21462230.
9. Jones RD, Jampani HB, Newman JL, Lee AS, (2000) Triclosan: A review of effectiveness and safety in health care settings. Am J Infect Control 28: 184-196. doi:10.1067/mic.2000.102378. PubMed: 10760227.
10. Schweizer HP, (2001) Triclosan: a widely used biocide and its link to antibiotics. FEMS Microbiol Lett 202: 1-7. doi:10.1111/j.1574-6968.2001.tb10772.x. PubMed: 11506900.
11. Heath RJ, Rubin JR, Holland DR, Zhang E, Snow ME, et al. (1999) Mechanism of triclosan inhibition of bacterial fatty acid synthesis. J Biol Chem 274: 11110-11114. doi:10.1074/jbc.274.16.11110. PubMed: 10196195.
12. Lubarsky HV, Gerbersdorf SU, Hubas C, Behrens S, Ricciardi F, et al. (2012) Impairment of the bacterial biofilm stability by triclosan. PLOS ONE 7: e31183. doi:10.1371/journal.pone.0031183. PubMed: 22523534.
13. Russell AD, (2004) Whither triclosan? J Antimicrob Chemother 53: 693-695. doi:10.1093/jac/dkh171. PubMed: 15073159.
14. Ghosh S, Cremers CM, Jakob U, Love NG, (2011) Chlorinated phenols control the expression of the multidrug resistance efflux pump MexAB-OprM in Pseudomonas aeruginosa by interacting with NalC. Mol Microbiol 79: 1547-1556. doi:10.1111/j.1365-2958.2011.07544.x. PubMed: 21231970.
15. McMurry LM, Oethinger M, Levy SB, (1998) Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol Lett 166: 305-309. doi:10.1111/j.1574-6968.1998.tb13905.x. PubMed: 9770288.
16. Braoudaki M, Hilton AC, (2004) Adaptive resistance to biocides in Salmonella enterica and Escherichia coli O157 and cross-resistance to antimicrobial agents. J Clin Microbiol 42: 73-78. doi:10.1128/JCM.42.1.73-78.2004. PubMed: 14715734.
17. Randall LP, Cooles SW, Piddock LJV, Woodward MJ, (2004) Effect of triclosan or a phenolic farm disinfectant on the selection of antibiotic-resistent Salmonella enterica. J Antimicrob Chemother 54: 621-627. doi:10.1093/jac/dkh376. PubMed: 15269199.
18. Lambert RJ, (2004) Comparative analysis of antibiotic and antimicrobial biocide susceptibility data in clinical isolates of methicillin-sensitive Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa between 1989 and 2000. J Appl Microbiol 97: 699-711. doi:10.1111/j.1365-2672.2004.02345.x. PubMed: 15357719.
19. Stickler DJ, Jones GL, (2008) Reduced susceptibility of Proteus mirabilis to triclosan. Antimicrob Agents Chemother 52: 991-994. doi:10.1128/AAC.01094-07. PubMed: 18180352.
20. Webber MA, Randall LP, Cooles SW, Woodward MJ, Piddock LJV, (2008) Triclosan resistance in Salmonella enterica serovar Typhimurium. J Antimicrob Chemother 62: 83-91. doi:10.1093/jac/dkn137. PubMed: 18388112.
21. Rensch U, Klein G, Schwarz S, Kaspar H, de Jong A, et al. (2013) Comparative analysis of the susceptibility to triclosan and three other biocides of avian Salmonella enterica isolates collected 1979 through 1994 and 2004 through 2010. J Food Protect 76: 653-656. doi:10.4315/0362-028X.JFP-12-420. PubMed: 23575128.
22. Copitch JL, Whitehead RN, Webber MA, (2010) Prevalence of decreased susceptibility to triclosan in Salmonella enterica isolates from animals and humans and association with multiple drug resistance. Int J Antimicrob Agents 36: 247-251. doi:10.1016/j.ijantimicag.2010.04.012. PubMed: 20541914.
23. Nishino K, Nikaido E, Yamaguchi A, (2009) Regulation and physiological function of multidrug efflux pumps in Escherichia coli and Salmonella. Biochim Biophys Acta 1794: 834-843. doi:10.1016/j.bbapap.2009.02.002. PubMed: 19230852.
24. Abouzeed YM, Baucheron S, Cloeckaert A, (2008) ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 52: 2428-2434. doi:10.1128/AAC.00084-08. PubMed: 18443112.
25. Kehrenberg C, Cloeckaert A, Klein G, Schwarz S, (2009) Decreased fluoroquinolone susceptibility in mutants of Salmonella serovars other than Typhimurium: detection of novel mutations involved in modulated expression of ramA and soxS. J Antimicrob Chemother 64: 1175-1180. doi:10.1093/jac/dkp347. PubMed: 19778917.
26. Yamasaki S, Nikaido E, Nakashima R, Sakurai K, Fujiwara D, et al. (2013) The crystal structure of multidrug-resistance regulator RamR with multiple drugs. Nat Commun 4: 2078. PubMed: 23800819.
27. Randall LP, Cooles SW, Piddock LJV, Woodward MJ, (2004) Mutant prevention concentrations of ciprofloxacin and enrofloxacin for Salmonella enterica. J Antimicrob Chemother 54: 688-691. doi:10.1093/jac/dkh360. PubMed: 15243029.
28. Drlica K, (2003) The mutant selection window and antimicrobial resistance. J Antimicrob Chemother 52: 11-17. doi:10.1093/jac/dkg269. PubMed: 12805267.
29. Clinical and Laboratory Standards Institute (2013) Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard- fourth edition. CLSI Document VET01-A4. Wayne, PA, USA: CLSI.
30. Preisler A, Mraheil MA, Heisig P, (2006) Role of novel gyrA mutations in the suppression of the fluoroquinolone resistance genotype of vaccine strain Salmonella Typhimurium vacT (gyrA D87G). J Antimicrob Chemother 57: 430-436. doi:10.1093/jac/dki475. PubMed: 16431864.
31. Olliver A, Vallé M, Chaslus-Dancla E, Cloeckaert A, (2004) Role of an acrR mutation in multidrug resistance of in vitro-selected fluoroquinolone-resistant mutants of Salmonella enterica serovar Typhimurium. FEMS Microbiol Lett 238: 267-272. doi:10.1016/j.femsle.2004.07.046. PubMed: 15336432.
32. Olliver A, Vallé M, Chaslus-Dancla E, Cloeckaert A, (2005) Overexpression of the multidrug efflux operon acrEF by insertional activation with IS1 or IS10 elements in Salmonella enterica serovar Typhimurium DT204 acrB mutants selected with fluoroquinolones. Antimicrob Agents Chemother 49: 289-301. doi:10.1128/AAC.49.1.289-301.2005. PubMed: 15616308.
33. Michael GB, Cardoso M, Schwarz S, (2008) Molecular analysis of multiresistant porcine Salmonella enterica subsp. enterica serovar Bredeney isolates from Southern Brazil: identification of resistance genes, integrons and a group II intron. Int J Antimicrob Agents 32: 120-129. doi:10.1016/j.ijantimicag.2008.02.024. PubMed: 18571903.
34. Tabak M, Scher K, Hartog E, Romling U, Matthews KR, et al. (2007) Effect of triclosan on Salmonella Typhimurium at different growth stages and in biofilms. FEMS Microbiol Lett 267: 200-206. doi:10.1111/j.1574-6968.2006.00547.x. PubMed: 17156099.
35. Zheng J, Cui S, Meng J, (2009) Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium. J Antimicrob Chemother 63: 95-102. PubMed: 18984645.
36. Pfaffl MW, Horgan GW, Dempfle L, (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30: e36. doi:10.1093/nar/30.9.e36. PubMed: 11972351.
37. Kehrenberg C, de Jong A, Friederichs S, Cloeckaert A, Schwarz S, (2007) Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations. J Antimicrob Chemother 59: 886-892. doi:10.1093/jac/dkm072. PubMed: 17369276.
38. Baucheron S, Imberechts H, Chaslus-Dancla E, Cloeckaert A, (2002) The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar Typhimurium phage type DT204. Microb Drug Resist 8: 281-289. doi:10.1089/10766290260469543. PubMed: 12523625.
39. McMurry LM, Oethinger M, Levy SB, (1998) Triclosan targets lipid synthesis. Nature 394: 531-532. doi:10.1038/28970. PubMed: 9707111.
40. Cottell A, Denyer SP, Hanlon GW, Ochs D, Maillard JY, (2009) Triclosan-tolerant bacteria: changes in susceptibility to antibiotics. J Hosp Infect 72: 71-76. doi:10.1016/j.jhin.2009.01.014. PubMed: 19246121.
41. Loughlin MF, Jones MV, Lambert PA, (2002) Pseudomonas aeruginosa cells adapted to benzalkonium chloride show resistance to other membrane-active agents but not to clinically relevant antibiotics. J Antimicrob Chemother 49: 631-639. doi:10.1093/jac/49.4.631. PubMed: 11909837.
42. Joynson JA, Forbes B, Lambert RJ, (2002) Adaptive resistance to benzalkonium chloride, amikacin and tobramycin: the effect on susceptibility to other antimicrobials. J Appl Microbiol 93: 96-107. doi:10.1046/j.1365-2672.2002.01667.x. PubMed: 12067378.
43. Karatzas KA, Randall LP, Webber M, Piddock LJ, Humphrey TJ, et al. (2008) Phenotypic and proteomic characterization of multiply antibiotic-resistant variants of Salmonella enterica serovar Typhimurium selected following exposure to disinfectants. Appl Environ Microbiol 74: 1508-1516. doi:10.1128/AEM.01931-07. PubMed: 18083849.